CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tetratherix Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tetratherix Ltd
Unit 29 34-36 Ralph Street, Sydney
ALEXANDRIA, NSW  2015  Australia Ticker: TTXTTX
Business Summary
Tetratherix Limited is an Australia-based company, which has developed a bio stealth fluid matrix that evolves regenerative medicine. The Company's biomaterial platform is built with polymer programming akin to Medical Lego to form implantable products to solve a range of clinical problems. The material is an injectable fluid to avoid causing damage to the body during its application. Upon injection, triggered by physiological temperature, a 3D matrix is formed that physically integrates and adheres to the target tissue. Tegenix and TegenEOS products are developed as a carrier designed to be mixed with a broad array of bone graft materials (BGMs) for dental, oral and orthopedic applications. TetraDerm products can be used in any surgical incision site to reduce scarring. Tutelix products are intended for use as a spacer to reduce side effects from radiation therapy in prostate cancer. It has established its manufacturing center in Sydney, featuring a cleanroom production facility.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20246/30/2024-----

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board EmmaCleary 3/13/2025 3/13/2025
Chief Executive Officer, Managing Director, Executive Director WilliamKnox 8/23/2021 8/23/2021
Co-Founder, Chief Operating Officer TerenceAbrams 9/1/2015 9/1/2015
8 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 50,331,637 (As of 12/31/2024)
Stock Exchange: ASX


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 20, 2025